20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T67898 | α-Glucosidase-IN-22 | Glucosidase | |
α-Glucosidase-IN-22 is a selective inhibitor of α-glucosidase (IC50=0.64 μM). α-Glucosidase-IN-22 has antidiabetic activity and has potential in type 2 diabetes (T2DM) studies. | |||
T67728 | α-Glucosidase-IN-23 | Glucosidase | |
α-Glucosidase-IN-23 is an orally active α-Glucosidase inhibitor. α-Glucosidase-IN-23 can decrease blood glucose by α-glucosidase inhibition (IC50= 4.48 μM). | |||
T41028 | α-Glucosidase | α-D-Glucosidase | |
α-Glucosidase (α-D-Glucosidase) is a carbohydrate hydrolyzing enzyme that catalyzes the release of α-glucose from the non-reducing end of the substrate. It plays a vital role in facilitating glucose absorption by the sma... | |||
T60715 | α-Glucosidase-IN-4 | Glucosidase | |
α-Glucosidase-IN-4 is a potent α-glucosidase inhibitor with antihypertensive and hypoglycemic activity. | |||
T76110 | β-Glucosidase | ||
β-Glucosidase, a pivotal enzyme in cellulose degradation, belongs to the extensive family of glycoside hydrolases. It plays a crucial role in breaking down cellulose in soils and holds promise for assessing biological so... | |||
T3S0860 | Gitogenin | UGT | |
1. Gitogenin, tigogenin, and solasodine are novel selective inhibitors of UGT1A4, and do not inhibit the activities of major human CYP isoforms. 2. Gitogenin and (25S)-5α-furastan-3β, 22, 26-triol are the inhibitors of e... | |||
T63562 | α-Glucosidase-IN-14 | ||
α-Glucosidase-IN-14 is a potent inhibitor of α-glucosidase (IC50: 5.22 μM). | |||
T62222 | α-Glucosidase-IN-11 | ||
α-Glucosidase-IN-11 is a highly permeable competitive inhibitor of α-glucosidase (IC50: 0.56 μM). α-Glucosidase-IN-11 binds to the Trp residue in α-glucosidase and has a regulatory effect on protein folding and can be us... | |||
T61519 | α-Glucosidase-IN-18 | ||
α-Glucosidase-IN-18 (7B) is an orally active inhibitor of α-glucosidase, displaying an IC 50 value of 3.96 μM. This compound exhibits antidiabetic properties [1]. | |||
T61166 | α-Glucosidase-IN-16 | ||
α-Glucosidase-IN-16 is a highly effective and orally bioavailable inhibitor of α-glucosidase, displaying a remarkable IC50 value of 3.28 μM. This compound demonstrates the ability to significantly decrease blood glucose ... | |||
T61124 | α-Glucosidase-IN-9 | ||
α-Glucosidase-IN-9 (compound 7) is a highly potent α-glucosidase inhibitor with an IC50 of 55.6 μM, making it suitable for type II diabetes research [1]. | |||
T60389 | α-Glucosidase-IN-5 | ||
α-Glucosidase-IN-5 (compound 8) is isolated from a twig extract of Polyalthia cinnamomea which is a potent α-glucosidase inhibitor with an IC50 of 57.9 µM. α-Glucosidase-IN-5 has the potential for the research of diabete... | |||
T79237 | α-Glucosidase-IN-27 | Glucosidase | |
α-Glucosidase-IN-27 (compound 8l), an α-glucosidase inhibitor with an IC50 value of 25.78 μM, demonstrates potential for research into type 2 diabetes (D2M) [1]. | |||
T78794 | α-Glucosidase-IN-31 | Glucosidase | |
α-Glucosidase-IN-31 (compound R1) is a potent oral α-Glucosidase inhibitor with an IC50 of 10.1 μM, demonstrating significant blood glucose reduction and antidiabetic activity [1]. | |||
T79700 | α-Glucosidase-IN-32 | Glucosidase | |
α-Glucosidase-IN-32 (compound f26) is a reversible, noncompetitive inhibitor of α-glucosidase that is orally active and exhibits an IC50 of 3.07 μM. It forms a complex with α-glucosidase via hydrogen bonding and hydropho... | |||
T80709 | α-Glucosidase-IN-41 | Glucosidase | |
α-Glucosidase-IN-41 (compound 5o), a potent inhibitor of α-glucosidase, induces alterations in the secondary structure of the enzyme, thereby impeding its catalytic function. This compound is utilized in the study of dia... | |||
T78740 | α-Glucosidase-IN-28 | Glucosidase | |
α-Glucosidase-IN-28 (Compound 18) is an α-glucosidase inhibitor with an IC50 of 0.62 μM and Ki value of 3.93 μM. It interacts with the enzyme's original binding site (OBS) and establishes multiple hydrophobic interaction... | |||
T63310 | α-Glucosidase-IN-6 | ||
α-Glucosidase-IN-6 is a competitive inhibitor of α-glucosidase (IC50: 5.69 μM) and exhibits potential for anti-diabetic studies. | |||
T61503 | α-Glucosidase-IN-15 | ||
α-Glucosidase-IN-15 (Compound 14B) exhibits potent inhibitory activity against α-glucosidase, with an IC50 value of 3.34 μM. It possesses antidiabetic properties [1]. | |||
T62972 | α-Glucosidase-IN-17 | ||
α-Glucosidase-IN-17 (Compound 12B) is a potent and orally active inhibitor of α-glucosidase, demonstrating antidiabetic activity with an inhibitory concentration (IC50) of 3.79 μM [1]. |